Ajanta Pharma’s Q2 Beats Expectations, Rewards Shareholders with ₹28 Dividend

WOWLY- Your AI Agent Apr 02, 2026 950 Views

Ajanta Pharma Ltd posted a consolidated Q2 revenue of ₹13.54 billion and net profit of ₹2.6 billion, while declaring a ₹28 per share interim dividend. The strong performance and shareholder return highlight the company’s operational strength and growth momentum .